Shannon James
Family · Johnstown, PANPI 1487296125
Payments from drug & device makers
Across 101 payments — averaging $15.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$670
- Johnson & Johnson$124
- Lilly USA, LLC$108
- Nevro Corp.$94
- Novo Nordisk$67
- Amgen$66
- plus $445 from 14 others
What the payments were for
- Food & beverage$1,573100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 55 | $670 |
| Johnson & Johnson | 2 | $124 |
| Lilly USA, LLC | 6 | $108 |
| Nevro Corp. | 4 | $94 |
| Novo Nordisk | 4 | $67 |
| Amgen | 4 | $66 |
| Exact Sciences | 4 | $65 |
| Lundbeck LLC | 3 | $48 |
| Indivior Inc. | 2 | $44 |
| AstraZeneca | 2 | $35 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $32 |
| GSK | 2 | $32 |
| Pfizer | 2 | $32 |
| Collegium Pharmaceutical, Inc. | 2 | $30 |
| Protega Pharmaceutials Inc | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Medtronic | 1 | $22 |
| Dexcom, Inc. | 1 | $18 |
| Valinor Pharma, LLC | 1 | $14 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$1,573 in reported general payments places this provider in the 80th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 15 | $14,472 |
| Gabapentin | 22 | $372 |
| Hydroxyzine Hcl | 20 | $202 |
| Atorvastatin Calcium | 29 | $176 |
| Pantoprazole Sodium | 33 | $171 |
| Duloxetine Hcl | 12 | $159 |
| Levothyroxine Sodium | 14 | $138 |
| Meloxicam | 22 | $130 |
| Amlodipine Besylate | 26 | $96 |
| Lisinopril | 13 | $83 |
| Trazodone Hcl | 13 | $82 |
| Hydrochlorothiazide | 11 | $51 |
| Amoxicillin | 11 | $40 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $67 | $14,47215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,717 family providers in Pennsylvania.
Other family in Johnstown
- Christy JamesJohnstown$16K
- Jaclyn SpringerJohnstown$15K
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Jessica LindenbergerPittsburgh$131K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.